Acquisition Significantly Expands Valeant’s Dermatology franchise in U.S. Newly approved dermatology product to be launched in early 2009 Five pipeline products in active development ALISO VIEJO, Calif., Dec. 10 (HSMN NewsFeed) — Valeant Pharm…
Biopharmaceuticals, Dermatology, Mergers & Acquisitions
Valeant Pharmaceuticals, Dow Pharma Sciences

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Valeant to Acquire Dow Laboratory Sciences, Inc. for $285 Million”
Leave a Comment